메뉴 건너뛰기




Volumn 36, Issue 48, 2015, Pages 3467-3470

Improving outcomes in heart failure: A personal perspective†

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENKEPHALINASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; MINERALOCORTICOID RECEPTOR; NATRIURETIC FACTOR; PEPTIDE HORMONE; PROTEINASE; SPIRONOLACTONE; CARDIOTONIC AGENT;

EID: 84959929177     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv565     Document Type: Review
Times cited : (34)

References (34)
  • 1
    • 0019499305 scopus 로고
    • Neurohumoral control mechanisms in congestive heart failure
    • Cohn JN, Levine TB, Francis GS, Goldsmith S. Neurohumoral control mechanisms in congestive heart failure. Am Heart J 1981;102:509-514.
    • (1981) Am Heart J , vol.102 , pp. 509-514
    • Cohn, J.N.1    Levine, T.B.2    Francis, G.S.3    Goldsmith, S.4
  • 2
    • 85047678771 scopus 로고
    • Evolution and the cardiac patient
    • Harris P. Evolution and the cardiac patient. Cardiovasc Res 1983;17:313-319.
    • (1983) Cardiovasc Res , vol.17 , pp. 313-319
    • Harris, P.1
  • 3
    • 0023266532 scopus 로고
    • Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
    • Effects of enalapril on mortality in severe congestive heart failure, The CONSENSUS Trial Study Group
    • Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-1435.
    • (1987) N Engl J Med , vol.316 , pp. 1429-1435
  • 4
    • 0025913812 scopus 로고
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
    • The SOLVD Investigators
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991; 325:293-302.
    • (1991) N Engl J Med , vol.325 , pp. 293-302
  • 5
    • 0019352579 scopus 로고
    • A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
    • de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28:89-94.
    • (1981) Life Sci , vol.28 , pp. 89-94
    • De Bold, A.J.1    Borenstein, H.B.2    Veress, A.T.3    Sonnenberg, H.4
  • 6
    • 0023749503 scopus 로고
    • Significance of atrial natriuretic factor in chronic heart failure
    • McMurray J, Struthers AD. Significance of atrial natriuretic factor in chronic heart failure. Br J Hosp Med 1988;40:55-57.
    • (1988) Br J Hosp Med , vol.40 , pp. 55-57
    • McMurray, J.1    Struthers, A.D.2
  • 7
    • 0024494050 scopus 로고
    • Atrial natriuretic factor inhibits isoproterenol-and furosemide-stimulated renin release in humans
    • McMurray JJ, Struthers AD. Atrial natriuretic factor inhibits isoproterenol-and furosemide-stimulated renin release in humans. Hypertension 1989;13:9-14.
    • (1989) Hypertension , vol.13 , pp. 9-14
    • McMurray, J.J.1    Struthers, A.D.2
  • 8
    • 0023772825 scopus 로고
    • Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man
    • McMurray J, Coutie WJ, McFarlane L, Struthers AD. Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man. Eur J Clin Pharmacol 1988;35:409-412.
    • (1988) Eur J Clin Pharmacol , vol.35 , pp. 409-412
    • McMurray, J.1    Coutie, W.J.2    McFarlane, L.3    Struthers, A.D.4
  • 10
    • 0032403704 scopus 로고    scopus 로고
    • Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition
    • Newby DE, McDonagh T, Currie PF, Northridge DB, Boon NA, Dargie HJ. Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition. Eur Heart J 1998;19:1808-1813.
    • (1998) Eur Heart J , vol.19 , pp. 1808-1813
    • Newby, D.E.1    McDonagh, T.2    Currie, P.F.3    Northridge, D.B.4    Boon, N.A.5    Dargie, H.J.6
  • 11
    • 0033086884 scopus 로고    scopus 로고
    • Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure
    • Northridge DB, Currie PF, Newby DE, McMurray JJ, Ford M, Boon NA, Dargie HJ. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure. Eur J Heart Fail 1999;1:67-72.
    • (1999) Eur J Heart Fail , vol.1 , pp. 67-72
    • Northridge, D.B.1    Currie, P.F.2    Newby, D.E.3    McMurray, J.J.4    Ford, M.5    Boon, N.A.6    Dargie, H.J.7
  • 12
    • 0035869572 scopus 로고    scopus 로고
    • Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
    • Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JM, McMurray JJ. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol 2001;37:1056-1061.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1056-1061
    • Petrie, M.C.1    Padmanabhan, N.2    McDonald, J.E.3    Hillier, C.4    Connell, J.M.5    McMurray, J.J.6
  • 13
    • 0035834157 scopus 로고    scopus 로고
    • Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymasespecific substrate [Pro(11)(D)-Ala(12)] angiotensin i in human dorsal hand veins: In vivo demonstration of non-ace production of angiotensin II in humans
    • McDonald JE, Padmanabhan N, Petrie MC, Hillier C, Connell JM, McMurray JJ. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymasespecific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans. Circulation 2001;104:1805-1808.
    • (2001) Circulation , vol.104 , pp. 1805-1808
    • McDonald, J.E.1    Padmanabhan, N.2    Petrie, M.C.3    Hillier, C.4    Connell, J.M.5    McMurray, J.J.6
  • 14
    • 0041408235 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced leftventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial
    • McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced leftventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial. Lancet 2003;362:767-771.
    • (2003) Lancet , vol.362 , pp. 767-771
    • McMurray, J.J.1    Ostergren, J.2    Swedberg, K.3    Granger, C.B.4    Held, P.5    Michelson, E.L.6    Olofsson, B.7    Yusuf, S.8    Pfeffer, M.A.9
  • 15
    • 0041909380 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial
    • Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial. Lancet 2003;362:772-776.
    • (2003) Lancet , vol.362 , pp. 772-776
    • Granger, C.B.1    McMurray, J.J.2    Yusuf, S.3    Held, P.4    Michelson, E.L.5    Olofsson, B.6    Ostergren, J.7    Pfeffer, M.A.8    Swedberg, K.9
  • 16
    • 0041408234 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
    • Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003;362:777-781.
    • (2003) Lancet , vol.362 , pp. 777-781
    • Yusuf, S.1    Pfeffer, M.A.2    Swedberg, K.3    Granger, C.B.4    Held, P.5    McMurray, J.J.6    Michelson, E.L.7    Olofsson, B.8    Ostergren, J.9
  • 18
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Randomized Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 21
    • 0037143601 scopus 로고    scopus 로고
    • Comparison of omapatrilat and enalapril in patients with chronic heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)
    • Packer M, Califf RM, Konstam MA, Krum H, McMurray JJ, Rouleau JL, Swedberg K. Comparison of omapatrilat and enalapril in patients with chronic heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation 2002;106:920-926.
    • (2002) Circulation , vol.106 , pp. 920-926
    • Packer, M.1    Califf, R.M.2    Konstam, M.A.3    Krum, H.4    McMurray, J.J.5    Rouleau, J.L.6    Swedberg, K.7
  • 27
    • 0029983661 scopus 로고    scopus 로고
    • Concise guide to the management of heart failure-World Health Organization/Council on Geriatric Cardiology Task Force on Heart Failure Education
    • McMurray J. Concise guide to the management of heart failure-World Health Organization/Council on Geriatric Cardiology Task Force on Heart Failure Education. Am J Geriatr Cardiol 1996;5:13-30.
    • (1996) Am J Geriatr Cardiol , vol.5 , pp. 13-30
    • McMurray, J.1
  • 31
    • 22244447125 scopus 로고    scopus 로고
    • Heart failure management programs reduce readmissions and prolong survival
    • Stewart S, McAlister FA, McMurray JJ. Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med 2005;165:1311.
    • (2005) Arch Intern Med , vol.165 , pp. 1311
    • Stewart, S.1    McAlister, F.A.2    McMurray, J.J.3
  • 34
    • 84870556584 scopus 로고    scopus 로고
    • What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE
    • Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol 2012;60: 2349-2356.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 2349-2356
    • Campbell, R.T.1    Jhund, P.S.2    Castagno, D.3    Hawkins, N.M.4    Petrie, M.C.5    McMurray, J.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.